If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSNP.L Regulatory News (SNP)

  • There is currently no data for SNP

3rd Quarter Results

28 Oct 2022 10:14

RNS Number : 4893E
China Petroleum & Chemical Corp
28 October 2022
Β 

Β 

Β 

Β 

Β 

China Petroleum & Chemical Corporation

The Third Quarterly Report for 2022

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

28 October 2022

Beijing China

Important notice

l The Board of Directors, the Board of Supervisors of China Petroleum & Chemical Corporation ("Sinopec Corp." or "the Company") and its directors, supervisors and senior management warrant the authenticity, accuracy and completeness of the information contained in this report and there are no false representations, misleading statements or material omissions and severally and jointly accept full responsibility.

Β 

l The third quarterly report for 2022 was approved at the 13th meeting of the 8th Session of the Board of Directors of Sinopec Corp. All directors attended this meeting.

Β 

l Mr. Ma Yongsheng, Chairman, Mr. Yu Baocai, President, Ms. Shou Donghua, Chief Financial Officer and Head of the Financial Department of Sinopec Corp. warrant the authenticity, accuracy and completeness of the financial statements contained in this quarterly report.

Β 

l The financial statements in this quarterly report were not audited.

Β 

Β 

Β 

Β 

1. Principal financial data

1.1 Principal financial data and indicators

1.1.1 Principal financial data and indicators prepared in accordance with China Accounting Standards for Business Enterprises (CASs)

RMB million

Items

As of 30

September 2022

As of 31

December 2021

Change

(%)

Total assets

2,050,519

1,889,255

8.5

Total equity attributable to equity shareholders of the Company

781,273

775,102

0.8

Β 

Β 

RMB million

Nine-months period ended 30 September

Change

(%)

Β 2022

2021

(adjusted)

2021

(before adjustment)

Operating income

2,453,322

2,001,691

2,003,350

22.6

Net profit attributable to equity shareholders of the Company

56,660

60,029

59,892

(5.6)

Net profit attributable to equity shareholders of the Company excluding extraordinary gains and losses

55,452

58,720

58,720

(5.6)

Net cash flow from operating activities

59,244

116,744

115,723

(49.3)

Basic earnings per share (RMB)

0.468

0.496

0.495

(5.6)

Diluted earnings per share (RMB)

0.468

0.496

0.495

(5.6)

Weighted average return on net assets

(%)

7.28

7.89

7.92

(0.61)

percentage points

Note: The Company has completed the purchase of non-equity assets and liabilities of Sinopec Group Asset Management Co., Ltd. and Sinopec Beijing Yanshan Petrochemical Co., Ltd. on 1 December 2021. Sinopec Yizheng Chemical Fibre Company Limited, a subsidiary of Sinopec Corp., has completed the purchase of non-equity assets and liabilities of Sinopec Group Asset Management Co., Ltd. on 1 December 2021. The transactions described above have been accounted as business combination under common control, thus, the Company retroactively adjusted the relevant financial data.

Β 

Β 

1.1.2 Extraordinary items

Β 

Β 

RMB million

Extraordinary items

Three-months period ended 30 September 2022

Nine-months period ended 30 September 2022

(income) /expense

(income) /expense

Net gain on disposal of non-current assets

Β (114)

Β (249)

Donations

Β 23

Β 124

Government grants

Β (669)

Β (2,009)

Gains on holding and disposal of various investments

Β (69)

Β (194)

Other extraordinary (income) /expenses, net

Β (95)

Β 193

Subtotal

Β (924)

Β (2,135)

Tax effect

Β 198

Β 673

Total

Β (726)

Β (1,462)

Attributable to:

Equity shareholders of the Company

Β (638)

Β (1,208)

Minority interests

Β (88)

Β (254)

Β 

1.1.3 Principal financial data and indicators prepared in accordance with International Financial Reporting Standards (IFRS)

RMB million

Items

As of 30

September 2022

As of 31

December 2021

Change

Β (%)

Total assets

2,050,519

1,889,255

8.5

Total equity attributable to shareholders of the Company

780,394

774,182

0.8

Β 

Β 

RMB million

Nine-months period ended 30 September

Change

(%)

2022

2021

Β (adjusted)

2021

(before adjustment)

Net cash from operating activities

59,244

116,744

115,723

Β (49.3)

Operating profit

75,886

85,025

84,806

Β (10.7)

Net profit attributable to shareholders of the Company

57,284

60,892

60,755

Β (5.9)

Basic earnings per share (RMB)

0.473

0.503

0.502

Β (5.9)

Diluted earnings per share (RMB)

0.473

0.503

0.502

Β (5.9)

Return on net assets (%)

7.34

7.88

7.91

(0.54)

percentage points

Note: The Company has completed the purchase of non-equity assets and liabilities of Sinopec Group Asset Management Co., Ltd. and Sinopec Beijing Yanshan Petrochemical Co., Ltd. on 1 December 2021. Sinopec Yizheng Chemical Fibre Company Limited, a subsidiary of Sinopec Corp., has completed the purchase of non-equity assets and liabilities of Sinopec Group Asset Management Co., Ltd. on 1 December 2021. The transactions described above have been accounted as business combination under common control, thus, the Company retroactively adjusted the relevant financial data.

Β 

1.2 Significant changes in major items contained in the consolidated financial statements prepared in accordance with CASs.

Items of Consolidated Balance Sheet

As of 30 September 2022

As of 31 December

2021

Increase/ (Decrease)

Main reasons for changes

Amount

Percentage

RMB million

RMB million

RMB million

(%)

Financial assets held for trading

1,030

-

1,030

-

Impact of increase in structured deposits.

Derivative financial assets

43,768

18,371

25,397

138.2

Impact of changes in profit and loss of crude oil and other products hedging business.

Derivative financial liabilities

16,454

3,223

13,231

410.5

Accounts receivable

65,796

34,861

30,935

88.7

Increase in accounts receivable resulting from increased prices of crude oil and refined oil products.

Prepayments

12,162

9,267

2,895

31.2

Prepayment for goods increased year-on-year.

Employee benefits payable

26,665

14,048

12,617

89.8

Impact of increase in payable performance-based income.

Taxes payable

30,214

81,267

(51,053)

(62.8)

The impact of centralized payment for deferred taxes happened in the fourth quarter of last year.

Non-current liabilities due within one year

69,574

28,651

40,923

142.8

Increase in long-term loans and debentures payable due within one year.

Other current liabilities

103,849

31,762

72,087

227.0

Increase in low-interest debentures for supplementary of liquidity during the reporting period.

Treasury shares

375

-

375

-

Repurchased A shares and H shares in the reporting period.

Other comprehensive income

7,587

(690)

8,277

-

The impact on translation of foreign currency statements and changes in effective hedging business.

Specific reserve

3,588

2,664

924

34.7

The impact of changes in balance of safety fund reserve.

Β 

Items of Consolidated Income Statement

Nine-months period ended 30 September

2022

Nine-months period ended 30 September

2021

Increase/ (Decrease)

Main reasons for changes

Amount

Percentage

RMB

million

RMB

million

RMB million

(%)

Other income

5,848

1,671

4,177

250.0

Increase in VAT refund on imported LNG.

Investment (loss) /income

(6,011)

9,520

(15,531)

-

Decrease in investment income of associates and joint ventures and the impact of profit and loss of derivative financial instruments.

Gains/ (loss) from changes in fair value

1,765

(1,112)

2,877

-

Impact of floating profit and loss of derivative financial instruments.

Impairment losses

(2,376)

(1,036)

(1,340)

129.3

Allowance for diminution in value of inventories increased.

Β 

Items of Consolidated Cash Flow Statement

Nine-months period ended 30 September

2022

Nine-months period ended 30 September

2021

Increase/(Decrease)

Main reasons for changes

Amount

Percentage

RMB

million

RMB

million

RMB

million

(%)

Net cash flow from operating activities

59,244Β 

116,744

(57,500)

(49.3)

Increase in working capital occupation due to the higher prices of crude oil and refined oil product.

Refunds of taxes and levies

8,401

934

7,467

799.5

Increase in VAT refund on imported LNG.

Other cash received relating to operating activities

211,117

109,232

101,885

93.3

Increase in derivative financial instruments margins received.

Cash paid for goods and services

(2,180,888)

(1,650,303)

(530,585)

32.2

Increase in procurement cost of crude oil and other feedstocks.

Other cash paid relating to operating activities

(247,067)

(122,068)

(124,999)

102.4

Increase in payment of derivative financial instruments margins.

Cash received from disposal of investment

517

6,614

(6,097)

(92.2)

Decrease in structured deposits received year on year.

Cash received from returns on investment

8,718

6,461

2,257

34.9

Increase in dividend received from associates and joint ventures.

Net cash received from disposal of fixed assets, intangible assets and other long-term assets

218

919

(701)

(76.3)

Decrease of gain on disposal of fixed assets.

Net cash received from disposal of subsidiaries and other business entities

1

4,764

(4,763)

(100.0)

Payment of pipeline transaction received in the same period of 2021 and no such item in reporting period.

Other cash received relating to investing activities

52,283

26,431

25,852

97.8

Increase in amount received of time deposits with maturities over three months.

Cash paid for acquisition of investments

(6,350)

(18,595)

12,245

(65.9)

Decrease in entrusted loan year on year.

Net cash paid for the acquisition of subsidiaries and other business entities

(7,641)

(1,114)

(6,527)

585.9

Cash paid for the prior year-end asset acquisition.

Other cash paid relating to investing activities

(23,172)

(36,949)

13,777

(37.3)

Decrease in time deposits with maturities over three months year on year.

Cash received from borrowings

432,081

298,393

133,688

44.8

Increase in loans.

Cash repayments of borrowings

(332,437)

(252,759)

(79,678)

31.5

Increase in matured debts year on year.

Cash paid for dividends, profits distribution or interest

(65,759)

(44,820)

(20,939)

46.7

The payment of dividends for the period increased year on year.

Β 

2. Shareholders information

Total number of shareholders and top ten shareholders at the end of the reporting period

Total number of shareholders at the end of the reporting period

Total number of shareholders was 479,394, including 473,819 holders of domestic A shares and 5,575 holders of overseas H shares.

Top ten shareholders

Name of shareholder

Total number of shares held

Percentage

(%)

Number of shares subject to pledge or lock-ups

Nature of shareholder

China Petrochemical Corporation

82,709,227,393

68.31

0

State-owned share

HKSCC (Nominees) Limited

25,371,033,298

20.96

Unknown

H share

2,325,374,407

1.92

0

A share

1,203,674,433

0.99

0

A share

005LCT001

394,236,547

0.33

0

A share

315,223,600

0.26

0

A share

235,021,324

0.19

0

A share

50

124,680,276

0.10

0

A share

83,162,900

0.07

0

A share

77,458,009

0.06

0

A share

Note: Sinopec Century Bright Capital Investment Limited, overseas wholly-owned subsidiary of China Petrochemical Corporation, holds 767,916,000 H shares, accounting for 0.6343% of the total issued share capital of Sinopec Corp. Those shareholdings were included in the total number of the shares held by HKSCC Nominees Limited.

Β 

Statement on the connected relationship or acting in concert among the aforementioned shareholders:

Sinopec Corp. is not aware of any connected relationship or acting in concert among or between the above-mentioned shareholders.

Β 

3. Review of operating results

In the first three quarters of 2022, the world economic growth slowed down. China effectively coordinated pandemic prevention and control with economic and social development and the overall economic operations recovered in an upward trend in the third quarter with the GDP growth of 3.9% year-on-year. The international crude oil prices rose sharply and fluctuated in the first half and dropped in the third quarter. The average spot price of Platts Brent was USD102.5 per barrel, up by 50.8% year-on-year. Domestic demand for natural gas kept stable. Based on the statistics of the Company, domestic demand for refined oil products shrank for the first half of the year and recovered with an increase of 1.5% year-on-year in the third quarter. The demand for major chemical products was weak due to the high crude oil price and the pandemic, with the ethylene equivalent consumption decreased by 1.0% year-on-year.

Β 

Confronted with severe and complex environment of production and operation, the Company gave full play to its integration advantages, actively responded to market changes, carried out in-depth optimization of the whole industrial chain, enhanced production and marketing coordination and achieved high-quality results. In accordance with CASs, net profit attributable to equity shareholders of the Company was RMB 56.660 billion, down by 5.6% year-on-year. In accordance with IFRS, net profit attributable to equity shareholders of the Company was RMB 57.284 billion, down by 5.9% year-on-year.

Β 

Exploration and Production: The Company seized the favourable opportunity of high oil prices, intensified efforts in exploration and development, consolidated the foundation of resources, improved operational performance, and realised growth in production and profit. In terms of exploration, we strengthened risk exploration and trap pre-exploration in new regions and areas, and achieved a number of oil and gas discoveries, including breakthroughs in Shunbei oil and gas fields and Tarim Basin, shale oilfield in Bohai Bay basin and Subei basin, deep exploration of natural gas in Sichuan basin. In terms of development, we accelerated capacity building of major oilfields, such as Shunbei, Tahe and offshore blocks, strengthened efficiency adjustment and fine-tuned development of mature oil fields. We also actively promoted the capacity building of key natural gas blocks in Shunbei and Sichuan basin, and enhanced optimization and profitability improvement of the whole natural gas business chain. In the first three quarters of 2022, the Company's production of oil and gas reached 363.18 million barrels of oil equivalent, up by 2.3% year-on-year, with crude oil production reaching 210.82 million barrels, up by 1.0% year-on-year and natural gas production reaching 913.8 billion cubic feet, up by 4.1% year-on-year. The exploration and production segment realised earnings before interest and tax (EBIT) of RMB 46.245 billion in the first three quarters.

Exploration and Production

Unit

Nine-month period ended 30 September

Changes

2022

2021

(%)

Oil and gas production

million boe

363.18

355.01

2.3

Crude oil production

million barrels

210.82

208.65

1.0

China

million barrels

188.05

186.59

0.8

Overseas

million barrels

22.77

22.06

3.2

Natural gas production

billion cubic feet

913.81

877.85

4.1

Realised crude oil price

USD/barrel

94.24

60.94

54.6

Realised natural gas price

USD/thousand cubic feet

7.54

6.74

11.9

Conversion: For domestic production of crude oil, 1 tonne = 7.10 barrels. For overseas production of crude oil,

1 tonne = 7.05 barrels. For production of natural gas, 1 cubic meter = 35.31 cubic feet.

Β 

Refining: The Company actively responded to challenges brought by high crude oil price and the pandemic, insisted on optimization and integration of production and marketing, leveraged the adaptability of facilities and maintained stable operation. We flexibly adjusted the utilization rate, product slate and export pace closely in line with market and reduced the inventory scale. We optimized the crude oil procurement and resources allocation to reduce procurement costs. We continuously promoted to increase the yield of chemical feedstock and refining specialities, accelerated construction of advanced capacity, promoted structural adjustment projects in an orderly manner and expedited the hydrogen supply projects. In the first three quarters of 2022, the Company processed 180 million tonnes crude oil, down by 5.6% year-on-year, yielding 103 million tonnes of refined oil products, among which diesel output increased by 4.7% year-on-year. The refining segment realised EBIT of RMB 20.645 billion in the first three quarters.Β 

Refining

Unit

Nine-month period ended 30 September

Changes

2022

2021

(%)

Refinery throughput

million tonnes

180.07

190.73

(5.6)

Gasoline, diesel and kerosene production

million tonnes

103.07

108.60

(5.1)

Gasoline

million tonnes

44.98

49.07

(8.3)

Diesel

million tonnes

44.92

42.92

4.7

Kerosene

million tonnes

13.17

16.60

(20.7)

Light chemical feedstock production

million tonnes

32.21

33.71

(4.4)

Light product yield

%

73.95

73.72

0.23 percentage points

Refining yield

%

95.11

94.71

0.40 percentage points

Note : Including 100% production of domestic joint ventures.

Β 

Marketing and Distribution: Facing the unfavourable situation of sporadic COVID-19 outbreaks in different regions, the Company strengthened the integration of production and marketing, scientifically adjusted business strategy and optimized the resources allocation. Especially, we seized the favorable opportunity of the gradual recovery of demand and continuous standardization of market orderliness in the third quarter and spared no effort to expand sales and increase profitability. We actively expanded low-sulphur bunker fuel market and further consolidated our market position. We expanded business scope, promoted branding building and improved the quality and profitability of non-fuel business. Efforts were made to accelerate sales network development, digitisation and transformation to an integrated energy service provider of petrol, gas, hydrogen, power and services. In the first three quarters, domestic sales volume of refined oil products was 121.99 million tonnes, among which the sales volume for the third quarter was 43.53 million tonnes, up by 16.4% quarter-on-quarter. The marketing and distribution segment realised EBIT of RMB 23.154 billion in the first three quarters.

Marketing and Distribution

Unit

Nine-month period ended 30 September

Changes

Β 

2022

2021

(%)

Β 

Total sales volume of refined oil products

million tonnes

151.60

166.59

(9.0)

Β 

Total domestic sales volume of refined oil products

million tonnes

121.99

127.88

(4.6)

Β 

Retail

million tonnes

79.09

83.70

(5.5)

Β 

Direct sales & Distribution

million tonnes

42.91

44.18

(2.9)

Β 

Annualised average throughput per station

tonnes/station

3,430

3,633

(5.6)

Β 

Note: The total sales volume of refined oil products includes the amount of refined oil marketing and trading sales volume.

Β 

Chemicals: Facing difficulty situation of high cost, high inventory and low margin in domestic chemical industrial chain, the Company closely responded to market change, dynamically optimized the structure of feedstocks and products, optimized utilization rate according to profitability, maintained high utilization rate in profitable facilities, increased the production of EVA and BR and increased production and profits in coal chemical business. We comprehensively promoted the construction of capacity in Zhenhai, Tianjin Nangang, Hainan and Jiujiang. In the first three quarters, ethylene production reached 10 million tonnes, up by 2.6% year-on-year. We made full efforts to ensure sufficient supply to our strategic customers, actively increased export, and vigorously expanded high-end markets. In the first three quarters, the total sales volume of chemical products was 60.40 million tonnes, with a slight decrease year-on-year. Due to the sharp decline of gross margin of chemical products, the chemicals segment realised EBIT of RMB -1.061 billion in the first three quarters.

Chemicals

Unit

Nine-month period ended 30 September

Changes

2022

2021

(%)

Ethylene

thousand tonnes

10,002

9,752

2.6

Synthetic resin

thousand tonnes

13,790

14,002

(1.5)

Synthetic rubber

thousand tonnes

936

890

5.2

Monomers and polymers for synthetic fibre

thousand tonnes

6,705

6,819

(1.7)

Synthetic fibre

thousand tonnes

834

1,031

(19.1)

Note : Including 100% production of domestic joint ventures.

Β 

Capital expenditures:

Capital expenditures in the first three quarters was RMB 104.0 billion, of which RMB 51.6 billion was spent in E&P segment, mainly for the crude oil capacity building in Shunbei and Tahe, natural gas capacity building in Chuanxi and Dongsheng, and the construction of storage and transportation facilities such as the relocation of Dongying crude oil depot and Longkou LNG projects; RMB 13.6 billion was spent in refining segment, mainly for Anqing and Yangzi refining upgrading projects and phase two of Zhenhai refining and chemical projects; RMB 6.5 billion was spent in marketing and distribution segment, mainly for the upgrading of existing stations and construction of integrated energy stations covering gasoline, gas, hydrogen, power and service, as well as logistics facilities; RMB 29.5 billion was spent in chemicals segment, mainly for Hainan and Tianjin Nangang ethylene projects, Jiujiang aromatics project, Zhenhai refining and chemical project phase II and Yizheng PTA project; RMB 2.8 billion was spent in corporate and others, mainly for construction of science and technology research and IT projects.

Β 

4. Other significant events

The progress of share repurchase

On 18 May 2022, the Annual General Meeting for 2021, the First A Shareholders Class Meeting for 2022 and the First H Shareholders Class Meeting for 2022 of Sinopec Corp. considered and approved the Resolution to Grant to the Board a Mandate to Buy Back Domestic Shares and/or Overseas-listed Foreign Shares of Sinopec Corp., and authorized the Board (or the director authorised by the Board) to buy back A Shares or H Shares not exceeding 10% of the number of A Shares or H Shares of the Company in issue.

On 26 August 2022, the twelfth meeting of the eighth session of the Board considered and approved the Plan on Repurchasing the Company's Shares by Centralized Bidding Transactions. For details, please refer to the Company's announcements disclosed on the website of the Shanghai Stock Exchange on 29 August 2022 and 20 September 2022.

On 21 September 2022, the Company implemented the repurchase of A shares and H shares. As of 30 September 2022, the Company has repurchased 48 million A shares, accounting for 0.04% of the Company's total issued share capital on 30 September 2022, and the total amount paid was RMB 203,905,495.60 (exclusive of transaction fees). For details, please refer to the Progress Announcement on the Repurchase of A Shares by Centralized Bidding Transactions disclosed by the Company on the website of the Shanghai Stock Exchange on 10 October 2022; the Company has repurchased 54.414 million H Shares, accounting for approximately 0.04% of the Company's total issued share capital on 30 September 2022, and the total amount paid was HK$188,781,540.60 (exclusive of transaction fees).

Β 

This quarterly results announcement is published in both Chinese and English languages. In the event of any inconsistency between the two versions, the Chinese version shall prevail.

Β 

By Order of the Board

Ma Yongsheng

Chairman

28 October 2022

Β 

Β 

5 Appendix

5.1 Quarterly financial statements prepared under China Accounting Standards for Business Enterprises (CASs)

Consolidated Balance Sheet

As at 30 September 2022

Prepared by: China Petroleum & Chemical Corporation

Units: million Currency: RMB Type: unaudited

Items

At 30 September 2022

At 31 December 2021

Current assets:

Β 

Β 

Cash at bank and on hand

216,728

Β 221,989

Financial assets held for trading

1,013

Β -

Derivative financial assets

43,768

Β 18,371

Accounts receivable

65,796

Β 34,861

Receivables financing

5,660

5,939

Prepayments

12,162

9,267

Other receivables

30,086

35,664

Inventories

282,719

207,433

Other current assets

19,463

24,500

Total current assets

677,395

558,024

Non-current assets:

Β 

Β 

Long-term equity investments

220,888

209,179

Other equity instrument investments

785

767

Fixed assets

602,977

598,932

Construction in progress

179,990

155,939

Right-of-use assets

180,769

184,974

Intangible assets

119,856

119,210

Goodwill

8,779

8,594

Long-term deferred expenses

10,934

10,007

Deferred tax assets

21,478

19,389

Other non-current assets

26,668

24,240

Total non-current assets

1,373,124

1,331,231

Total assets

2,050,519

1,889,255

Β 

Consolidated Balance Sheet (Continued)

Current liabilities:

Short-term loans

24,610

27,366

Derivative financial liabilities

16,454

3,223

Bills payable

10,096

11,721

Accounts payable

233,680

203,919

Contract liabilities

145,290

124,622

Employee benefits payable

26,665

14,048

Taxes payable

30,214

81,267

Other payables

124,461

114,701

Non-current liabilities due within one year

69,574

28,651

Other current liabilities

103,849

31,762

Total current liabilities

784,893

641,280

Non-current liabilities:

Β 

Β 

Long-term loans

81,873

49,341

Debentures payable

13,062

42,649

Lease liabilities

168,718

170,233

Provisions

46,475

43,525

Deferred tax liabilities

9,767

7,910

Other non-current liabilities

20,194

18,276

Total non-current liabilities

340,089

331,934

Total liabilities

1,124,982

973,214

Shareholders' equity:

Β 

Β 

Share capital

121,071

121,071

Capital reserve

118,118

120,188

Less: Treasury shares

375

-

Other comprehensive income

Β 7,587

(690)

Specific reserve

3,588

2,664

Surplus reserves

213,224

213,224

Retained earnings

318,060

318,645

Total equity attributable to shareholders of the Company

781,273

775,102

Minority interests

144,264

140,939

Total shareholders' equity

925,537

916,041

Total liabilities and shareholders' equity

2,050,519

1,889,255

Β 

Ma Yongsheng Yu Baocai Shou Donghua

Chairman President Chief Financial Officer

(Legal representative)

Β 

Β 

Balance Sheet

As at 30 September 2022

Prepared by: China Petroleum & Chemical Corporation

Units: million Currency: RMB Type: unaudited

Items

At 30 September 2022

At 31 December 2021

Current assets

Β 

Β 

Cash at bank and on hand

103,962

110,691

Financial assets held for trading

2

-

Derivative financial assets

15,368

4,503

Accounts receivable

28,510

21,146

Receivables financing

1,684

227

Prepayments

4,949

4,540

Other receivables

38,008

46,929

Inventories

82,074

63,661

Other current assets

18,573

23,408

Total current assets

293,130

275,105

Non-current assets

Β 

Β 

Long-term equity investments

376,299

360,847

Other equity instrument investments

201

201

Fixed assets

278,302

284,622

Construction in progress

78,198

66,146

Right-of-use assets

92,595

105,712

Intangible assets

7,782

9,334

Long-term deferred expenses

2,891

2,875

Deferred tax assets

7,490

8,715

Other non-current assets

42,113

34,227

Total non-current assets

885,871

872,679

Total assets

1,179,001

1,147,784

Current liabilities

Β 

Β 

Short-term loans

1,351

16,550

Derivative financial liabilities

12,269

1,121

Bills payable

1,440

6,058

Accounts payable

86,748

85,307

Contract liabilities

9,491

7,505

Employee benefits payable

17,143

8,398

Taxes payable

17,233

46,333

Other payables

218,198

211,179

Non-current liabilities due within one year

40,916

16,737

Other current liabilities

75,220

13,702

Total current liabilities

480,009

412,890

Β 

Balance Sheet (Continued)

Β 

Non-current liabilities

Long-term loans

52,390

34,258

Debentures payable

9,536

31,522

Lease liabilities

92,452

104,426

Provisions

37,679

35,271

Other non-current liabilities

2,764

3,103

Total non-current liabilities

194,821

208,580

Total liabilities

674,830

621,470

Shareholders' equity

Β 

Β 

Share capital

121,071

121,071

Capital reserve

66,469

67,897

Less: Treasury shares

375

-

Other comprehensive income

4,132

6,024

Specific reserve

1,997

1,658

Surplus reserves

213,224

213,224

Retained earnings

97,653

116,440

Total shareholders' equity

504,171

526,314

Total liabilities and shareholders' equity

1,179,001

1,147,784

Β 

Ma Yongsheng Yu Baocai Shou Donghua

Chairman President Chief Financial Officer

(Legal representative)

Β 

Β 

Consolidated Income Statement

For the nine-month period ended 30 September 2022

Prepared by: China Petroleum & Chemical Corporation

Units: million Currency: RMB Type: unaudited

Items

The third quarter of 2022 (July-September)

The third quarter of 2021 (July-September)

Nine-month period

ended 30 September 2022

Nine-month period

ended 30 September 2021

I. Operating income

841,196

740,918

2,453,322

2,001,691

II. Total Operating costs

837,227

714,314

2,374,159

1,916,509

Including: Operating costs

Β 735,800

Β 603,238

Β 2,066,625

Β 1,601,524

Taxes and surcharges

Β 65,817

Β 65,952

Β 200,226

Β 186,852

Selling and distribution expenses

Β 14,654

Β 16,616

Β 42,784

Β 48,347

General and administrative expenses

Β 13,439

Β 20,038

Β 39,622

Β 56,208

Research and development expenses

Β 2,778

Β 2,951

Β 9,088

Β 8,311

Financial expenses

Β 2,604

Β 2,352

Β 7,941

Β 7,254

Including: Interest expenses

Β 4,363

Β 3,896

Β 12,487

Β 11,556

Interest income

Β 1,581

Β 1,458

Β 4,593

Β 4,121

Exploration expenses,

including dry holes

Β 2,135

Β 3,167

Β 7,873

Β 8,013

Add: Other income

Β 3,727

Β 427

Β 5,848

Β 1,671

Investment income

Β 4,296

Β 4,630

Β (6,011)

Β 9,520

Including: Income from investment

in associates and joint ventures

3,950

5,903

11,277

17,036

Gains from changes in fair value

Β 3,323

Β (1,228)

Β 1,765

Β (1,112)

Credit impairment reversals/ (losses)

Β 67

Β (195)

Β 139

Β (140)

Impairment losses

Β (920)

Β (110)

Β (2,376)

Β (1,036)

Asset disposal gains

Β 114

Β 152

Β 249

Β 433

III. Operating profit

14,576

Β 30,280

78,777

94,518

Add: Non-operating income

Β 822

Β 500

Β 1,677

Β 1,196

Less: Non-operating expenses

Β 743

Β 670

Β 1,822

Β 1,751

IV. Profit before taxation

14,655

30,110

Β 78,632

93,963

Less: Income tax expense

1,261

Β 5,979

15,722

Β 21,031

V. Net profit

13,394

Β 24,131

62,910

Β 72,932

Including: net (loss) /profit of acquiree before business combination under common control

-

(62)

-

211

Classification by going concern:

Β 

Β 

Β 

Β 

(i) Continuous operating net profit

13,394

24,131

62,910

72,932

(ii) Termination of net profit

-

-

-

Β -

Β 

Consolidated Income Statement (Continued)

Classification by ownership:

Β 

Β 

Β 

Β 

(i) Equity shareholders of the Company

Β 13,130

Β 20,603

Β 56,660

Β 60,029

(ii) Minority interests

Β 264

Β 3,528

Β 6,250

Β 12,903

VI. Other comprehensive income

1,628

3,355

18,335

11,463

Items that may not be reclassified subsequently to profit or loss:

Β (2)

Β 1

Β (19)

Β 9

Changes in fair value of other equity instrument investments

Β (2)

Β 1

Β (19)

Β 9

Items that may be reclassified subsequently to profit or loss:

Β 1,630

Β 3,354

18,354

11,454

Other comprehensive income that can be converted into profit or loss under the equity method

Β (1,617)

Β 87

1,780

208

Cost of hedging reserve

Β 506

Β (20)

(338)

(60)

Cash flow hedges

Β (2,483)

Β 3,066

7,775

11,706

Foreign currency translation differences

Β 5,224

Β 221

9,137

(400)

VII. Total comprehensive income

15,022

27,486

81,245

84,395

Equity shareholders of the Company

Β 13,807

Β 24,032

73,370

Β 71,442

Minority interests

Β 1,215

Β 3,454

7,875

Β 12,953

VIII. Earnings per share

Β 

Β 

Β 

Β 

(i) Basic earnings per share (RMB/Share)

Β 0.108

0.170

Β 0.468

Β 0.496

(ii) Diluted earnings per share (RMB/Share)

Β 0.108

0.170

0.468

Β 0.496

Β 

Β 

Ma Yongsheng Yu Baocai Shou Donghua

Chairman President Chief Financial Officer

(Legal representative)

Β 

Income Statement

For the nine-month period ended 30 September 2022

Prepared by: China Petroleum & Chemical Corporation

Units: million Currency: RMB Type: unaudited

Items

The third quarter of 2022 (July-September)

The third quarter of 2021 (July-September)

Nine-month period

ended 30 September 2022

Nine-month period

ended 30 September 2021

I. Operating income

Β 329,242

Β 265,651

Β 979,672

734,773

Less: Operating costs

271,636

Β 203,170

792,959

566,597

Taxes and surcharges

Β 41,749

Β 39,146

Β 128,206

Β 111,871

Selling and distribution expenses

Β 383

Β 884

Β 1,598

Β 2,750

General and administrative expenses

Β 5,585

Β 9,353

Β 17,250

Β 25,739

Research and development expenses

1,467

Β 2,637

7,310

Β 7,599

Financial expenses

Β 2,731

Β 2,845

Β 7,726

Β 8,227

Including: Interest expenses

Β 3,466

Β 2,228

Β 10,259

Β 6,421

Interest income

Β 878

Β 662

Β 2,614

1,822

Exploration expenses, including dry holes

1,924

Β 2,847

Β 6,718

Β 7,029

Add: Other incomeΒ 

Β 3,209

Β 201

Β 4,654

Β 944

Investment income

Β 6,366

Β 12,337

Β 23,666

Β 22,939

Including: Income from investment in associates and joint ventures

942

1,979

3,956

6,345

Gains from changes in fair value

Β (513)

Β (243)

Β (272)

Β (11)

Credit impairment reversals

Β 3

Β 6

Β 2

Β 8

Impairment losses

Β 10

Β 1

Β (726)

Β (752)

Asset disposal gains

Β 3

Β 9

Β 124

Β 6

II. Operating profit

Β 12,845

Β 17,080

Β 45,353

Β 28,095

Add: Non-operating income

Β 492

Β (7)

Β 673

Β 196

Less: Non-operating expenses

Β 358

Β 289

Β 1,029

Β 808

III. Profit before taxation

Β 12,979

Β 16,784

44,997

Β 27,483

Less: Income tax expense

2,093

Β 1,381

6,608

Β 4,194

IV. Net profit

10,886

Β 15,403

38,389

23,289

(i) Continuous operating net profit

10,886

Β 15,403

38,389

23,289

(ii) Termination of net profit

-

-

-

-

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Income Statement (continued)

V. Other comprehensive income

(13)

Β 4,444

4,743

10,398

Items that may not be reclassified subsequently to profit or loss:

-

-

(5)

-

Changes in fair value of other equity instrument investments

-

-

(5)

-

Items that may be reclassified subsequently to profit or loss:

Β (13)

Β 4,444

4,748

10,398

Other comprehensive income that can be converted into profit or loss under the equity method

Β (14)

Β 90

Β 125

Β 108

Cash flow hedges

Β 1

Β 4,354

Β 4,623

Β 10,290

VI. Total comprehensive income

10,873

19,847

43,132

33,687

Β 

Ma Yongsheng Yu Baocai Shou Donghua

Chairman President Chief Financial Officer

(Legal representative)

Β 

Consolidated Cash Flow Statement

For the nine-month period ended 30 September 2022

Prepared by: China Petroleum & Chemical Corporation

Units: million Currency: RMB Type: unaudited

Items

Nine-month period

ended 30 September 2022

Nine-month period

ended 30 September 2021

I. Cash flows from operating activities:

Β 

Β 

Cash received from sale of goods and rendering of services

2,627,885

2,112,459

Refund of taxes and levies

8,401

934

Other cash received relating to operating activities

211,117

109,232

Sub-total of cash inflows

2,847,403

2,222,625

Cash paid for goods and services

(2,180,888)

(1,650,303)

Cash paid to and for employees

(61,586)

(57,226)

Payments of taxes and levies

(298,618)

(276,284)

Other cash paid relating to operating

activities

(247,067)

(122,068)

Sub-total of cash outflows

(2,788,159)

(2,105,881)

Net cash flow from operating activities

59,244

116,744

II. Cash flows from investing activities:

Β 

Cash received from disposal of investments

517

6,614

Cash received from returns on investments

8,718

6,461

Net cash received from disposal of fixed assets, intangible assets and other long-term assets

218

919

Net cash received from disposal of subsidiaries and other business entities

1

4,764

Other cash received relating to investing

activities

52,283

26,431

Sub-total of cash inflows

61,737

45,189

Cash paid for acquisition of fixed assets, intangible assets and other long-term assets

(94,485)

(88,602)

Cash paid for acquisition of investments

(6,350)

(18,595)

Cash paid for acquisition of subsidiaries and other business unitsΒ 

(7,641)

(1,114)

Other cash paid relating to investing activities

(23,172)

(36,949)

Sub-total of cash outflows

(131,648)

(145,260)

Net cash flow from investing activities

(69,911)

(100,071)

III. Cash flows from financing activities:

Β 

Β 

Cash received from capital contributions

1,935

604

Including: Cash received from minority shareholders' capital contributions to subsidiaries

1,935

604

Β 

Consolidated Cash Flow Statement (Continued)

Cash received from borrowings

432,081

298,393

Other cash received relating to financing activities

1,347

115

Sub-total of cash inflows

435,363

299,112

Cash repayments of borrowings

(332,437)

(252,759)

Cash paid for dividends, profits distribution or interest

(65,759)

(44,820)

Including: Subsidiaries' cash payments for distribution of dividends or profits to minority shareholders

(4,360)

(5,741)

Other cash paid relating to financing

activities

(13,290)

(14,762)

Sub-total of cash outflows

(411,486)

(312,341)

Net cash flow from financing activities

23,877

(13,229)

IV. Effects of changes in foreign exchange rate

4,798

(177)

V. Net increase in cash and cash equivalents

18,008

3,267

Add: Initial balance of cash and cash equivalents

108,590

87,559

VI. Ending balance of cash and cash equivalents

126,598

90,826

Β 

Β 

Ma Yongsheng Yu Baocai Shou Donghua

Chairman President Chief Financial Officer

(Legal representative)

Β 

Cash Flow Statement

For the nine-month period ended 30 September 2022

Prepared by: China Petroleum & Chemical Corporation

Units: million Currency: RMB Type: unaudited

Items

Nine-month period

ended 30 September 2022

Nine-month period

ended 30 September 2021

I. Cash flows from operating activities:

Β 

Β 

Cash received from sale of goods and rendering of services

1,100,876

805,374

Refund of taxes and levies

5,731

602

Other cash received relating to operating activities

13,893

8,306

Sub-total of cash inflows

1,120,500

814,282

Cash paid for goods and services

(837,202)

(582,164)

Cash paid to and for employees

(31,695)

(29,678)

Payments of taxes and levies

(175,552)

(154,927)

Other cash paid relating to operating activities

(53,355)

(14,208)

Sub-total of cash outflows

(1,097,804)

(780,977)

Net cash flow from operating activities

22,696

33,305

II. Cash flows from investing activities:

Β 

Β 

Cash received from disposal of investments

5,038

16,642

Cash received from returns on investments

23,123

17,791

Net cash received from disposal of fixed assets, intangible assets and other long-term assets

45

56

Other cash received relating to investing activities

146,656

93,230

Sub-total of cash inflows

174,862

127,719

Cash paid for acquisition of fixed assets, intangible assets and other long-term assets

(42,868)

(38,050)

Cash paid for acquisition of investments

(20,452)

(37,610)

Cash paid for acquisition of subsidiaries and other business unitsΒ 

(4,221)

(964)

Other cash paid relating to investing activities

(136,949)

(93,843)

Sub-total of cash outflows

(204,490)

(170,467)

Net cash flow from investing activities

(29,628)

(42,748)

III. Cash flows from financing activities:

Β 

Β 

Cash received from borrowings

187,385

151,145

Other cash received relating to financing activities

294,614

220,822

Sub-total of cash inflows

481,999

371,967

Cash repayments of borrowings

(121,305)

(121,860)

Cash paid for dividends or interest

(63,082)

(41,086)

Other cash paid relating to financing activities

(288,135)

(206,415)

Sub-total of cash outflows

(472,522)

(369,361)

Net cash flow from financing activities

9,477

2,606

Β 

Cash Flow Statement (Continued)

IV. Effects of changes in foreign exchange rate

(8)

-

V. Net increase/ (decrease) in cash and cash equivalents

2,537

(6,837)

AddInitial balance of cash and cash equivalents

34,575

28,081

VI. Ending balance of cash and cash equivalents

37,112

21,244

Β 

Β 

Ma Yongsheng Yu Baocai Shou Donghua

Chairman President Chief Financial Officer

(Legal representative)

Β 

Β 

Segment Reporting

For the nine-month period ended 30 September 2022

Prepared by: China Petroleum & Chemical Corporation

Units: million Currency: RMB Type: unaudited

Items

Nine-month period

ended 30 September 2022

Nine-month period

ended 30 September 2021

Income from principal operations

Β 

Β 

Exploration and production

Β 

Β 

External sales

Β 138,870

Β 104,139

Inter-segment sales

Β 92,164

Β 61,683

Subtotal

Β 231,034

Β 165,822

Refining

Β 

Β 

External sales

Β 148,241

Β 122,238

Inter-segment sales

Β 1,028,879

Β 862,823

Subtotal

Β 1,177,120

Β 985,061

Marketing and distribution

Β 

Β 

External sales

Β 1,227,731

Β 977,324

Inter-segment sales

Β 9,886

Β 4,745

Subtotal

Β 1,237,617

Β 982,069

Chemicals

Β 

Β 

External sales

Β 342,259

Β 306,570

Inter-segment sales

Β 60,194

Β 48,973

Subtotal

Β 402,453

Β 355,543

Corporate and others

Β 

Β 

External sales

Β 550,609

Β 446,160

Inter-segment sales

Β 775,647

Β 527,164

Subtotal

Β 1,326,256

Β 973,324

Elimination of inter-segment sales

(1,966,770)

(1,505,388)

Consolidated income from principal operations

2,407,710

1,956,431

Income from other operations

Β 

Β 

Exploration and production

Β 4,465

Β 5,011

Refining

Β 2,874

Β 3,723

Marketing and distribution

Β 28,952

Β 27,216

Chemicals

Β 7,496

Β 7,754

Corporate and others

Β 1,825

Β 1,556

Consolidated income from other operations

Β 45,612

Β 45,260

Consolidated operating income

2,453,322

Β 2,001,691

Β 

Segment Reporting (Continued)

Operating profit

Β 

Β 

By segment

Β 

Β 

Exploration and production

Β 39,165

Β 7,673

Refining

Β 20,023

Β 53,310

Marketing and distribution

Β 21,759

Β 22,416

Chemicals

Β (4,502)

Β 15,087

Corporate and others

Β 15,632

Β 4,609

Elimination

Β (7,210)

Β (11,835)

Total segment operating profit

Β 84,867

Β 91,260

Investment income

Β 

Β 

Exploration and production

Β 2,848

Β 2,698

Refining

Β (74)

Β 785

Marketing and distribution

Β 494

Β 1,626

Chemicals

Β 2,986

Β 7,500

Corporate and others

Β (12,265)

Β (3,089)

Total segment investment (loss) /income

(6,011)

9,520

Financial expenses

(7,941)

(7,254)

Gains/ (losses) from changes in fair value

1,765

(1,112)Β 

Asset disposal gains

249

433

Other income

5,848

1,671

Operating profit

78,777

94,518

Add: Non-operating income

Β 1,677

Β 1,196

Less: Non-operating expenses

Β 1,822

Β 1,751

Profit before taxation

78,632

93,963

Β 

Β 

5.2 Quarterly financial statements prepared under International Financial Reporting Standards (IFRS)

Consolidated Income Statement

For the nine-month period ended 30 September 2022

Prepared by: China Petroleum & Chemical Corporation

Units: million Currency: RMB Type: unaudited

Items

Current Amount

(July-September)

Amount of the previous period (July-September)

Nine-month period ended 30 September 2022

Nine-month period ended 30 September 2021

Revenue

Β 

Β 

Β 

Β 

Revenue from primary business

Β 825,474

Β 724,908

Β 2,407,710

Β 1,956,431

Other operating revenues

Β 15,722

Β 16,010

Β 45,612

Β 45,260

Subtotal

Β 841,196

Β 740,918

Β 2,453,322

Β 2,001,691

Operating expenses

Β 

Β 

Β 

Β 

Purchased crude oil, products and

operating supplies and expenses

Β (700,430)

Β (576,176)

Β (1,962,613)

(1,521,731)

Selling, general and administrative expenses

Β (13,965)

Β (13,383)

Β (40,762)

Β (39,193)

Depreciation, depletion and amortisation

Β (27,911)

Β (28,282)

Β (81,549)

Β (82,748)

Exploration expenses, including dry holes

Β (2,135)

Β (3,167)

Β (7,873)

Β (8,013)

Personnel expenses

Β (25,264)

Β (24,937)

Β (74,487)

Β (70,132)

Taxes other than income tax

Β (65,817)

Β (65,952)

Β (200,226)

Β (186,852)

Impairment reversals/ (losses) on trade and other receivables

Β 67

Β (195)

Β 139

Β (140)

Other operating income/ (expense), net

Β 7,221

Β (2,287)

Β (10,065)

Β (7,857)

Total operating expenses

Β (828,234)

Β (714,379)

Β (2,377,436)

Β (1,916,666)

Operating profit

Β 12,962

Β 26,539

Β 75,886

85,025

Finance costs

Β 

Β 

Β 

Β 

Interest expense

Β (4,363)

Β (3,896)

Β (12,487)

Β (11,556)

Interest income

Β 1,581

Β 1,458

Β 4,593

Β 4,121

Foreign currency exchange gains/ (losses), net

178

86

(47)

181

Net finance costs

(2,604)

(2,352)

(7,941)

(7,254)

Investment income

Β 74

Β 79

Β 200

Β 193

Share of profits less losses from associates and joint ventures

Β 3,950

Β 5,903

Β 11,277

Β 17,036

Profit before taxation

14,382

Β 30,169

Β  79,422

Β 95,000

Income tax expense

(1,261)

Β (5,979)

(15,722)

Β (21,031)

Profit for the period

13,121

Β 24,190

63,700

73,969

Attributable to

Β 

Β 

Β 

Β 

Owners of the Company

12,833

Β 20,665

57,284

Β 60,892

Non-controlling interests

Β 288

Β 3,525

Β 6,416

Β 13,077

Profit for the period

13,121

24,190

63,700

Β 73,969

Earnings per share

Β 

Β 

Β 

Β 

Basic earnings per share (RMB)

Β 0.106

Β 0.171

Β 0.473

Β 0.503

Diluted earnings per share (RMB)

Β 0.106

Β 0.171

Β 0.473

Β 0.503

Consolidated Statement of Comprehensive Income

For the nine-month period ended 30 September 2022

Prepared by: China Petroleum & Chemical Corporation

Units: million Currency: RMB Type: unaudited

Β 

Items

Current Amount

(July-September)

Amount of the previous period

(July-September)

Nine-month period

ended 30 September 2022

Nine-month period

ended 30 September 2021

Profit for the period

13,121

24,190

63,700

73,969

Other comprehensive income:

1,628

3,355

18,335

11,463

Items that may not be reclassified subsequently to profit or loss:

Equity investments at fair value through other comprehensive income

(2)

1

(19)

9

Items that may be reclassified subsequently to profit or loss:

Share of other comprehensive income of associates and joint ventures

(1,617)

87

1,780

208

Cash flow hedges

Β (2,483)

Β 3,066

7,775

Β 11,706

Cost of hedging reserve

Β 506

Β (20)

(338)

Β (60)

Foreign currency translation differences

5,224

221

9,137

(400)

Total comprehensive income for the period

14,749Β 

27,545

82,035

85,432

Attributable to:

Shareholders of the Company

13,510

Β 24,091

73,994

Β 72,302

Non-controlling interests

Β 1,239

Β 3,454

Β 8,041

Β 13,130

Β 

Β 

Consolidated Balance Sheet

For the nine-month period ended 30 September 2022

Prepared by: China Petroleum & Chemical Corporation

Units: million Currency: RMB Type: unaudited

Items

At 30 September 2022

At 31 December 2021

Non-current assets

Β 

Β 

Property, plant and equipment, net

602,881

598,925

Construction in progress

179,990

155,939

Right-of-use assets

266,013

268,408

Goodwill

8,779

8,594

Interest in associates

160,240

148,729

Interest in joint ventures

60,648

60,450

Financial assets at fair value through othercomprehensive income

785

767

Deferred tax assets

21,478

19,389

Long-term prepayments and other non-current assets

72,310

70,030

Total non-current assets

1,373,124

1,331,231

Current assets:

Cash and cash equivalents

126,598

108,590

Time deposits with financial institutions

90,130

113,399

Financial assets at fair value through profit and loss

1,013

-

Derivatives financial assets

43,768

18,371

Trade accounts receivable and bills receivable

65,796

34,861

Financial assets at fair value through othercomprehensive income

5,660

5,939

Inventories

282,719

207,433

Prepaid expenses and other current assets

61,711

69,431

Total current assets

677,395

558,024

Current liabilities

Short-term debts

128,556

35,252

Loans from Sinopec Group Company and fellowsubsidiaries

6,454

2,873

Lease liabilities

16,678

15,173

Derivatives financial liabilities

16,454

3,223

Trade accounts payable and bills payable

243,776

215,640

Contract liabilities

145,290

124,622

Other payables

225,242

239,688

Income tax payable

2,443

4,809

Total current liabilities

784,893

641,280

Consolidated Balance Sheet (Continued)

Net current liabilities

107,498

83,256

Total assets less current liabilities

1,265,626

1,247,975

Non-current liabilities

Long-term debts

79,789

78,300

Loans from Sinopec Group Company and fellow subsidiaries

15,146

13,690

Lease liabilities

168,718

170,233

Deferred tax liabilities

9,767

7,910

Provisions

46,475

43,525

Other non-current liabilities

21,117

19,243

Total non-current liabilities

341,012

332,901

Total net assets

924,614

915,074

Equity

Share capital

121,071

121,071

Reserves

659,323

653,111

Total equity attributable to shareholders of the Company

780,394

774,182

Non-controlling interests

144,220

140,892

Total equity

924,614

915,074

Β 

Β 

Consolidated Cash Flow Statement

For the nine-month period ended 30 September 2022

Prepared by: China Petroleum & Chemical Corporation

Units: million Currency: RMB Type: unaudited

Items

Nine-month period

ended 30 September 2022

Nine-month period

ended 30 September 2021

Net cash generated from operating activities(a)

59,244

116,744

Investing activities

Β 

Β 

Capital expenditure

(82,142)

(78,185)

Exploratory wells expenditure

(12,343)

(10,417)

Purchase of investments

(5,341)

(10,363)

Payment for financial assets at fair value through profit or loss

(1,009)

(8,232)

Proceeds from settlement of financial assets at fair value through profit or loss

6

4,739

Payment for acquisition of subsidiary, net of cash acquired

(7,641)

(1,114)

Proceeds from disposal of investments

512

6,639

Proceeds from disposal of property, plant, equipment and other non-current assets

218

919

Increase in time deposits with maturities over three months

(22,071)

(32,711)

Decrease in time deposits with maturities over three months

47,491

22,698

Interest received

3,489

2,407

Investment and dividend income received

8,718

6,461

Proceeds from/ (payments of) other investing activities

202

(2,912)

Net cash used in investing activities

(69,911)

(100,071)

Financing activities

Β 

Β 

Proceeds from bank and other loans

432,081

298,393

Repayments of bank and other loans

(332,437)

(252,759)

Contributions to subsidiaries from non-controlling interests

1,935

604

Dividends paid by the Company

(56,903)

(35,111)

Distributions by subsidiaries to non-controlling interests

(4,360)

(5,741)

Interest paid

(4,496)

(3,968)

Payments made to acquire non-controlling interests

-

(1,410)

Repayments of lease liabilities

(10,877)

(12,778)

Proceeds from other financing activities

1,347

115

Repayments of other financing activities

(2,413)

(574)

Net cash generated from/ (used in) financing activities

23,877

(13,229)

Net increase in cash and cash equivalents

13,210

3,444

Cash and cash equivalents at 1 January

108,590

87,559

Effect of foreign currency exchange rate changes

4,798

(177)

Cash and cash equivalents at 30 September

126,598

90,826

Note to consolidated statement of Cash Flows

For the nine-month period ended 30 September 2022

Prepared by: China Petroleum & Chemical Corporation

Units: million Currency: RMB Type: unaudited

(a) Reconciliation of profit before taxation to net cash generated from operating activities

Items

Nine-month period ended 30

September 2022

Nine-month period ended 30

September 2021

Operating activities

Β 

Β 

Profit before taxation

79,422

95,000

Adjustments for:

Β 

Β 

Depreciation, depletion and amortisation

81,549

82,748

Dry hole costs written off

5,556

5,427

Share of profits less losses from associates and joint ventures

(11,277)

(17,036)

Investment income

(200)

(193)

Interest income

(4,593)

(4,121)

Interest expense

12,487

11,556

(Gain) /loss on foreign currency exchange rate changes andΒ derivative financial instruments

(451)

1,203

Loss on disposal of property, plant, equipment andΒ other non-current assets, net

205

125

Impairment losses on assets

2,376

1,036

Impairment (reversals) /losses on trade and other receivables

(139)

140

Operating profit before change of operating capital

164,935

175,885

Accounts receivable and other current assets

(26,933)

(62,740)

Inventories

(77,664)

(46,565)

Accounts payable and other current liabilities

13,041

70,880

Subtotal

73,379

137,460

Income tax paid

(14,135)

(20,716)

Net cash generated from operating activities

59,244

116,744

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Segment Reporting

For the nine-month period ended 30 September 2022

Prepared by: China Petroleum & Chemical Corporation

Units: million Currency: RMB Type: unaudited

Items

Nine-month period

ended 30 September 2022

Nine-month period

ended 30 September 2021

Revenue from primary business

Β 

Β 

Exploration and production

Β 

Β 

External sales

Β 138,870

Β 104,139

Inter-segment sales

Β 92,164

Β 61,683

Subtotal

Β 231,034

Β 165,822

Refining

Β 

Β 

External sales

Β 148,241

Β 122,238

Inter-segment sales

Β 1,028,879

Β 862,823

Subtotal

Β 1,177,120

Β 985,061

Marketing and distribution

Β 

Β 

External sales

Β 1,227,731

Β 977,324

Inter-segment sales

Β 9,886

Β 4,745

Subtotal

Β 1,237,617

Β 982,069

Chemicals

Β 

Β 

External sales

Β 342,259

Β 306,570

Inter-segment sales

Β 60,194

Β 48,973

Subtotal

Β 402,453

Β 355,543

Corporate and others

Β 

Β 

External sales

Β 550,609

Β 446,160

Inter-segment sales

775,647

Β 527,164

Subtotal

Β 1,326,256

Β 973,324

Elimination of inter-segment sales

(1,966,770)

(1,505,388)

Revenue from primary business

2,407,710

1,956,431

Other operating revenues

Β 

Β 

Exploration and production

Β 4,465

Β 5,011

Refining

Β 2,874

Β 3,723

Marketing and distribution

Β 28,952

Β 27,216

Chemicals

Β 7,496

Β 7,754

Corporate and others

1,825

Β 1,556

Other operating revenues

45,612

Β 45,260

Revenue

2,453,322

Β 2,001,691

Β 

Β 

Segment Reporting (Continued)

Result

Β 

Β 

Operating profit/ (loss)

Β 

Β 

By segment

Β 

Β 

Exploration and production

Β 43,591

Β 8,708

Refining

Β 20,849

Β 53,567

Marketing and distribution

Β 21,120

Β 21,628

Chemicals

Β (4,037)

Β 15,757

Corporate and others

Β 1,573

Β (2,800)

Elimination

Β (7,210)

Β (11,835)

Total segment operating profit

75,886

Β 85,025

Share of profits/ (losses) from associates and joint ventures

Β 

Β 

Exploration and production

Β 2,654

Β 2,134

Refining

Β (245)

Β 728

Marketing and distribution

Β 1,994

Β 2,678

Chemicals

Β 3,131

Β 7,556

Corporate and others

Β 3,743

Β 3,940

Aggregate share of profits from associates and joint ventures

11,277

17,036

Investment income

Β 

Β 

Exploration and production

Β -

Β 62

Refining

Β 41

Β (1)

Marketing and distribution

Β 40

Β 10

Chemicals

Β (155)

Β (56)

Corporate and others

Β 274

Β 178

Aggregate investment income

200

193

Net finance costs

(7,941)

(7,254)

Profit before taxation

79,422

95,000

Β 

Β 

5.3 Differences between consolidated financial statements prepared in accordance with the accounting policies complying with the accounting policies complying with CASs and IFRS (Unaudited)

Β 

Other than the differences in the classifications of certain financial statements captions and the accounting for the items described below, there are no material differences between the Group's consolidated financial statements prepared in accordance with the accounting policies complying with CASs and IFRS. The reconciliation presented below is included as supplemental information, is not required as part of the basic financial statements and does not include differences related to classification, presentation or disclosures. Such information has not been subject to independent audit or review. The major differences are:

(i) Government grants

Under CASs, grants from the government are credited to capital reserve if required by relevant governmental regulations. Under IFRS, government grants relating to the purchase of fixed assets are recognised as deferred income and are transferred to the income statement over the useful life of these assets.

(ii) Safety production fund

Under CASs, safety production fund should be recognised in profit or loss with a corresponding increase in reserve according to PRC regulations. Such reserve is reduced for expenses incurred for safety production purposes or, when safety production related fixed assets are purchased, is reduced by the purchased cost with a corresponding increase in the accumulated depreciation. Such fixed assets are not depreciated thereafter. Under IFRS, payments are expensed as incurred, or capitalised as fixed assets and depreciated according to applicable depreciation methods.

Effects of major differences between the net profit under CASs and the profit for the period under IFRS are analysed as follows:

Prepared by: China Petroleum & Chemical Corporation

Units: million Currency: RMB Type: unaudited

Items

Nine-month period

ended 30 September 2022

Nine-month period

ended 30 September 2021

Net profit under CASs

62,910

72,932

Adjustments:

Government grants(i)

44

37

Safety production fund(ii)

1,088

1,000

Other

(342)

-

Profit for the period under IFRS

63,700

73,969

Β 

Β 

Effects of major differences between the shareholders' equity under CASs and the total equity under IFRS are analysed as follows:

Β 

Units: million Currency: RMB Type: unaudited

Items

As of 30 September 2022

As of 31 December 2021

Shareholders' equity under CASs

925,537

916,041

Adjustments:

Government grants(i)

(923)

(967)

Total equity under IFRS

924,614

915,074

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
QRTEANEPAFFAFEA
12
Date   Source Headline
28th Oct 202210:14 amRNS3rd Quarter Results
3rd Oct 20227:00 amRNSStatement re Intention to Delist ADSs from the LSE
30th Aug 20227:00 amRNSHalf-year Report
12th Aug 202210:23 amRNSINTENTION TO DELIST ADSs FROM THE NYSE
27th Jun 20229:46 amRNSReport on Payments to Govts
27th Apr 20229:47 amRNS1st Quarter Results
28th Mar 20227:00 amRNSAnnual Financial Report-2
28th Mar 20227:00 amRNSAnnual Financial Report-1
27th Jan 20229:49 amRNSTrading Statement
28th Oct 202110:54 amRNS3rd Quarter Results
31st Aug 20217:00 amRNSHalf-year Report
1st Jul 202111:36 amRNSTrading Statement
16th Jun 20219:46 amRNSReport on Payments to Govts
25th May 202111:31 amRNSResult of AGM
28th Apr 20219:39 amRNS1st Quarter Results
29th Mar 20217:00 amRNSEstimated Increase in Profit for Q1 2021
29th Mar 20217:00 amRNSAnnual Financial Report-part 2
29th Mar 20217:00 amRNSAnnual Financial Report
28th Oct 20208:56 amRNS3rd Quarter Results
1st Sep 20207:00 amRNSHalf-year Report
28th May 20209:46 amRNSReport on Payments to Govts
29th Apr 202010:03 amRNS1st Quarter Results
23rd Apr 202012:38 pmRNSAnnual Financial Report - Part 2
23rd Apr 202012:37 pmRNSAnnual Financial Report - Part 1
30th Mar 20207:00 amRNSFinal Results - Part 2
30th Mar 20207:00 amRNSFinal Results - Part 1
10th Dec 20199:37 amRNSStatement re Restructuring Oil&Gas Pipeline Assets
30th Oct 20199:16 amRNS3rd Quarter Results
27th Aug 20197:00 amRNSHalf-year Report
31st May 20199:36 amRNSReport on Payments to Govts
29th Apr 201911:49 amRNS1st Quarter Results
25th Mar 20198:19 amRNSFinal Results - Part 2
25th Mar 20198:17 amRNSFinal Results - Part 1
25th Jan 20199:21 amRNSProgress Update Announcement
25th Jan 20199:11 amRNSOperational Statistics for 2018
25th Jan 20199:07 amRNSAnnouncement on Preliminary Financial Data of 2018
4th Jan 201910:45 amRNSFurther re ANNOUNCEMENT UNUSUAL PRICE MOVEMENT
27th Dec 20182:19 pmRNSStmnt re Share Price Movement
30th Oct 201812:08 pmRNS3rd Quarter Results
16th Oct 201812:49 pmRNSEstimated Increase in Profit ended 30 Sep. 2018
28th Aug 20187:10 amRNSHalf-year Report
24th Jul 201810:13 amRNSEstimated Increase in Profit for the 1H 2018
13th Jun 201810:58 amRNSReport on Payments to Govts
15th May 20183:04 pmRNSResult of AGM
26th Apr 201811:31 amRNS1st Quarter Results
26th Mar 20187:23 amRNSAnnual Financial Report
30th Oct 201710:38 amRNS3rd Quarter Results
22nd Sep 201711:50 amRNSDirectorate Change
29th Aug 20177:00 amRNSHalf-year Report
30th Jun 201710:48 amRNSReport on Payments to Govts for 2015 and 2016
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.